Supernus Pharmaceuticals (NASDAQ:SUPN)

CAPS Rating: 1 out of 5

Recs

3
Player Avatar TMFBlacknGold (99.38) Submitted: 6/28/2012 11:28:38 PM : Underperform Start Price: $10.45 SUPN Score: +29.84

Man, I wish I got in on this one just a few days earlier (IPO debut). Still, this is about as safe as a red thumb gets. Supernus has shareholders' equity of just $270,000 as of 1Q12, which registers as a fair book value of a whopping $0.0113 per share. I will be looking to get a few picks in on this one to maximize my score. This is red thumb number one. What a joke of a company!

Report this Post 2 Replies
Member Avatar zzlangerhans (99.75) Submitted: 7/31/2012 6:12:52 AM
Recs: 2

I believe the IPO proceeds are not reflected in 1Q12 shareholders' equity.

Report this Post
Member Avatar TMFBlacknGold (99.38) Submitted: 8/8/2012 2:23:13 PM
Recs: 1

Ah thanks zz. Although I'm sure it won't make a big difference in the end.

Report this Post

Featured Broker Partners


Advertisement